Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 6/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL389440 | 1.00 | THRB (0.61) | THRBCA12CA1CA2CA9 | |
| SCHEMBL28671752 | 0.88 | CHRM2 (0.54) | THRBCA12CA1CA2CA9 | |
| SCHEMBL14984 | 0.88 | CHRM2 (0.54) | THRBCA12CA1CA2CA9 | |
| SCHEMBL6529961 | 0.87 | THRB (0.51) | THRBCA12CA1CA2CA9 | |
| SCHEMBL11650326 | 0.86 | CHRM2 (0.52) | THRBCA12CA1CA2CA9 | |
| Fluoride SCHEMBL1255040 | 0.86 | CHRM2 (0.52) | THRBCA12CA1CA2CA9 | |
| Ammonia Solution, Strong SCHEMBL8139148 | 0.86 | CHRM2 (0.52) | THRBCA12CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL129149 | 0.86 | CHRM2 (0.52) | THRBCA12CA1CA2CA9 | |
| Methyl Alcohol SCHEMBL21326731 | 0.86 | CHRM2 (0.52) | THRBCA12CA1CA2CA9 | |
| Bromide SCHEMBL1255341 | 0.86 | CHRM2 (0.52) | THRBCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8753615-B2 | Ethylene copolymer with PEG, cationic and anionic units, cosmetic composition including same and treatment method | L'OREAL (FR) | 2014-06-17 | — | — | US | disclosed |
| US-8753615-B2 | Ethylene copolymer with PEG, cationic and anionic units, cosmetic composition including same and treatment method | L'OREAL (FR) | 2014-06-17 | — | — | US | disclosed |
| US-20120070399-A1 | ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD | L'OREAL (FR) | 2012-03-22 | — | — | US | disclosed |
| US-20120070399-A1 | ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD | L'OREAL (FR) | 2012-03-22 | — | — | US | disclosed |
| WO-2010116063-A1 | ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD | L'OREAL (FR) | 2010-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120070399-A1 | ETHYLENE COPOLYMER WITH PEG, CATIONIC AND ANIONIC UNITS, COSMETIC COMPOSITION INCLUDING SAME AND TREATMENT METHOD | EGFR, ERCC1, ERCC5 | THRB 3970/4885CA12 1361/4885CA1 2962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.